CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | C4-dicarboxylic acid |
|
Accession: | CHEBI:66873
|
browse the term
|
Definition: | Any dicarboxylic acid that contains four carbon atoms. |
Synonyms: | related_synonym: | C4-dicarboxylic acids |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:61336 |
|
|
|
G |
Folh1 |
folate hydrolase 1 |
affects binding multiple interactions |
ISO |
isospaglumic acid binds to FOLH1 protein [2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid binds to Aminocaproic Acid binds to 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane binds to Valerates binds to bombesin (7-14) binds to Copper] inhibits the reaction [isospaglumic acid binds to FOLH1 protein] |
CTD |
PMID:24508213 |
|
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of ACTA2 mRNA] Artesunate results in decreased expression of ACTA2 mRNA; Artesunate results in decreased expression of ACTA2 protein Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:30551460 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
affects localization |
ISO |
artesunate affects the localization of AIFM1 protein |
CTD |
PMID:24704559 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
artesunate binds to and results in decreased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atg12 |
autophagy related 12 |
increases expression |
ISO |
Artesunate results in increased expression of ATG12 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg3 |
autophagy related 3 |
increases expression |
ISO |
Artesunate results in increased expression of ATG3 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
Artesunate results in increased expression of ATG5 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
Artesunate results in increased expression of BAX protein [1,2-Dimethylhydrazine co-treated with artesunate] results in increased expression of BAX protein |
CTD |
PMID:24704559 PMID:29031619 PMID:33002460 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
Artesunate results in decreased expression of BCL2 protein 3-methyladenine inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; acadesine promotes the reaction [Artesunate results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; dorsomorphin inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; Sirolimus promotes the reaction [Artesunate results in decreased expression of BCL2 protein] [1,2-Dimethylhydrazine co-treated with artesunate] results in decreased expression of BCL2 protein |
CTD |
PMID:24704559 PMID:29031619 PMID:33002460 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bst1 |
bone marrow stromal cell antigen 1 |
increases response to substance |
ISO |
BST1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
|
|
G |
Casp3 |
caspase 3 |
increases activity increases cleavage multiple interactions |
ISO |
artesunate results in increased activity of CASP3 protein Artesunate results in increased cleavage of CASP3 protein 3-methyladenine inhibits the reaction [Artesunate results in increased cleavage of CASP3 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Artesunate results in increased cleavage of CASP3 protein]; Sirolimus promotes the reaction [Artesunate results in increased cleavage of CASP3 protein] |
CTD |
PMID:19513562 PMID:24704559 PMID:33002460 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
affects expression |
ISO |
artesunate affects the expression of CASP9 protein |
CTD |
PMID:24704559 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression decreases response to substance |
ISO |
artesunate results in increased expression of CAT protein CAT protein results in decreased susceptibility to artesunate |
CTD |
PMID:19513562 PMID:20144594 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
EXP |
Artesunate results in decreased expression of CCND1 protein |
CTD |
PMID:32633561 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
EXP |
Artesunate results in decreased expression of CCNE1 protein |
CTD |
PMID:32633561 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cct2 |
chaperonin containing TCP1 subunit 2 |
decreases response to substance |
ISO |
CCT2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:52,692,725...52,705,478
Ensembl chr 7:52,692,725...52,706,944
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
EXP |
Artesunate results in decreased expression of CDK2 protein |
CTD |
PMID:32633561 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
EXP |
Artesunate results in decreased expression of CDK4 protein |
CTD |
PMID:32633561 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions increases phosphorylation |
ISO |
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK1 protein] |
CTD |
PMID:31664825 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions increases phosphorylation |
ISO |
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK2 protein] |
CTD |
PMID:31664825 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
increases response to substance |
ISO |
CLIP4 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 6:23,616,280...23,697,625 NCBI chr 6:23,718,580...23,729,231 NCBI chr 6:23,597,729...23,601,000
Ensembl chr 6:23,616,281...23,677,874
|
|
G |
Coq8a |
coenzyme Q8A |
decreases response to substance |
ISO |
COQ8A mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein] |
CTD |
PMID:29031619 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Dbh |
dopamine beta-hydroxylase |
increases response to substance |
ISO |
DBH mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Des |
desmin |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of DES mRNA] Artesunate results in decreased expression of DES mRNA; Artesunate results in decreased expression of DES protein |
CTD |
PMID:30551460 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
artesunate binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:25752796 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
artesunate results in increased expression of FAS protein |
CTD |
PMID:19513562 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Flna |
filamin A |
increases response to substance |
ISO |
FLNA mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of FN1 mRNA] Artesunate results in decreased expression of FN1 mRNA; Artesunate results in decreased expression of FN1 protein |
CTD |
PMID:30551460 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fth1 |
ferritin heavy chain 1 |
decreases expression multiple interactions |
ISO |
Artesunate results in decreased expression of FTH1 mRNA; Artesunate results in decreased expression of FTH1 protein Chloroquine inhibits the reaction [Artesunate results in decreased expression of FTH1 mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fzd7 |
frizzled class receptor 7 |
increases response to substance |
ISO |
FZD7 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects response to substance decreases response to substance |
ISO |
GCLC mRNA affects the susceptibility to artesunate GCLC mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases response to substance |
ISO |
GCLM mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases activity multiple interactions |
ISO |
Artesunate results in decreased activity of GPX4 protein Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of GPX4 protein] |
CTD |
PMID:30551460 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
affects response to substance |
ISO |
GSTM4 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
artesunate results in decreased expression of GSTP1 protein |
CTD |
PMID:19513562 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt2 |
glutathione S-transferase theta 2 |
affects response to substance |
ISO |
GSTT2 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
affects response to substance |
ISO |
GSTZ1 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases phosphorylation |
ISO |
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of H2AX protein] |
CTD |
PMID:31664825 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Artesunate inhibits the reaction [Ethanol results in increased expression of IL1B protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL1B protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Artesunate inhibits the reaction [Ethanol results in increased expression of IL6 protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL6 protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgb1 |
integrin subunit beta 1 |
increases response to substance |
ISO |
ITGB1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases lipidation |
ISO |
3-methyladenine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; acadesine promotes the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; dorsomorphin inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; Sirolimus promotes the reaction [Artesunate results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:33002460 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Mgst3 |
microsomal glutathione S-transferase 3 |
affects response to substance |
ISO |
MGST3 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein] |
CTD |
PMID:29031619 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP ISO |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein] Chloroquine inhibits the reaction [Artesunate results in decreased expression of MMP9 mRNA] |
CTD |
PMID:29031619 PMID:30551460 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
artesunate inhibits the reaction [Ethanol results in increased activity of MPO protein] |
CTD |
PMID:27474069 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
decreases response to substance |
ISO |
MTHFD2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
ISO |
acadesine promotes the reaction [Artesunate results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Artesunate results in decreased phosphorylation of MTOR protein]; dorsomorphin inhibits the reaction [Artesunate results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:33002460 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
EXP |
artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein] |
CTD |
PMID:30031708 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Naca |
nascent polypeptide associated complex subunit alpha |
decreases response to substance |
ISO |
NACA mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:468,862...481,992
Ensembl chr 7:469,723...481,992
|
|
G |
Nckap1 |
NCK-associated protein 1 |
increases response to substance |
ISO |
NCKAP1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 3:65,417,450...65,491,769
Ensembl chr 3:65,417,453...65,492,217
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
multiple interactions decreases expression |
ISO |
Chloroquine inhibits the reaction [Artesunate results in decreased expression of NCOA4 mRNA] Artesunate results in decreased expression of NCOA4 mRNA; Artesunate results in decreased expression of NCOA4 protein |
CTD |
PMID:30551460 |
|
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects localization |
ISO |
artesunate affects the localization of NFE2L2 protein |
CTD |
PMID:26340163 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
artesunate inhibits the reaction [Glucose results in increased expression of NLRP3 protein] |
CTD |
PMID:30031708 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
ISO |
Artesunate results in increased cleavage of PARP1 protein 3-methyladenine inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; acadesine promotes the reaction [Artesunate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; dorsomorphin inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; Sirolimus promotes the reaction [Artesunate results in increased cleavage of PARP1 protein] |
CTD |
PMID:24704559 PMID:33002460 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein] |
CTD |
PMID:29031619 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
artesunate binds to and results in increased activity of PGR protein |
CTD |
PMID:25752796 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 mRNA; [Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 protein |
CTD |
PMID:30551460 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
artesunate inhibits the reaction [Ethanol results in increased expression of RELA protein]; artesunate inhibits the reaction [Glucose results in increased phosphorylation of RELA protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rpa2 |
replication protein A2 |
increases phosphorylation |
ISO |
Artesunate results in increased phosphorylation of RPA2 protein |
CTD |
PMID:31664825 |
|
NCBI chr 5:144,976,789...144,989,445
Ensembl chr 5:144,976,748...144,987,350
|
|
G |
Rpl41 |
ribosomal protein L41 |
decreases response to substance |
ISO |
RPL41 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:977,885...978,965
|
|
G |
Rpl6 |
ribosomal protein L6 |
decreases response to substance |
ISO |
RPL6 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
|
|
G |
Rpl7 |
ribosomal protein L7 |
decreases response to substance |
ISO |
RPL7 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 5:3,217,184...3,220,192
|
|
G |
Rps12 |
ribosomal protein S12 |
decreases response to substance |
ISO |
RPS12 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014
|
|
G |
Rps15a |
ribosomal protein S15a |
decreases response to substance |
ISO |
RPS15A mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:172,420,151...172,427,021
Ensembl chr 1:172,419,761...172,426,995
|
|
G |
Rps6 |
ribosomal protein S6 |
decreases response to substance |
ISO |
RPS6 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Slc25a19 |
solute carrier family 25 member 19 |
decreases response to substance |
ISO |
SLC25A19 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:100,853,554...100,867,517
Ensembl chr10:100,847,168...100,867,447
|
|
G |
Sp1 |
Sp1 transcription factor |
decreases expression |
ISO |
artesunate results in decreased expression of SP1 protein |
CTD |
PMID:19513562 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions decreases expression |
ISO |
Chloroquine inhibits the reaction [Artesunate results in decreased expression of SQSTM1 protein] Artesunate results in decreased expression of SQSTM1 mRNA; Artesunate results in decreased expression of SQSTM1 protein |
CTD |
PMID:30551460 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
decreases response to substance |
ISO |
SRSF2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression multiple interactions |
ISO |
Artesunate results in increased expression of TIMP1 mRNA Chloroquine inhibits the reaction [Artesunate results in increased expression of TIMP1 mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
artesunate inhibits the reaction [Glucose results in increased expression of TLR4 protein] |
CTD |
PMID:30031708 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
artesunate inhibits the reaction [Ethanol results in increased expression of TNF protein]; artesunate inhibits the reaction [Glucose results in increased expression of TNF mRNA]; artesunate inhibits the reaction [Glucose results in increased secretion of TNF protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
Artesunate results in increased expression of TP53 protein Artesunate inhibits the reaction [TPT1 protein binds to TP53 protein] |
CTD |
PMID:33259807 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
affects response to substance multiple interactions |
ISO |
TPT1 protein affects the susceptibility to artesunate Artesunate binds to and results in decreased expression of TPT1 protein; Artesunate inhibits the reaction [TPT1 protein binds to TP53 protein] |
CTD |
PMID:15878303 PMID:33259807 |
|
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
decreases response to substance |
ISO |
TUFM mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:181,073,788...181,077,395
Ensembl chr 1:181,073,788...181,077,395
|
|
G |
Ulk1 |
unc-51 like autophagy activating kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Artesunate results in increased phosphorylation of ULK1 protein acadesine promotes the reaction [Artesunate results in increased phosphorylation of ULK1 protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased phosphorylation of ULK1 protein]; dorsomorphin inhibits the reaction [Artesunate results in increased phosphorylation of ULK1 protein] |
CTD |
PMID:33002460 |
|
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of VEGFA protein] |
CTD |
PMID:29031619 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Yy1 |
YY1 transcription factor |
decreases expression |
ISO |
artesunate results in decreased expression of YY1 protein |
CTD |
PMID:19513562 |
|
NCBI chr 6:127,706,739...127,736,499
Ensembl chr 6:127,707,596...127,732,747
|
|
G |
Zbtb4 |
zinc finger and BTB domain containing 4 |
increases response to substance |
ISO |
ZBTB4 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:54,480,698...54,501,492
Ensembl chr10:54,485,071...54,501,492
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCA1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCB4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ABCD1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr X:151,428,334...151,450,115
Ensembl chr X:151,428,578...151,450,115
|
|
G |
Abcd2 |
ATP binding cassette subfamily D member 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACAA1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACAA1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACAA1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:118,872,996...118,881,852
Ensembl chr 8:118,872,997...118,881,825
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACACB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACADS mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADS mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACADVL mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADVL mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Ache |
acetylcholinesterase |
decreases activity |
ISO EXP |
Aspartame metabolite results in decreased activity of ACHE protein |
CTD |
PMID:16129618 PMID:17580119 PMID:17673349 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Aco1 |
aconitase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACO1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACO1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACOT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ADGRE1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Agt |
angiotensinogen |
decreases expression |
ISO |
Aspartame results in decreased expression of AGT mRNA |
CTD |
PMID:31655124 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
ISO |
Aspartame results in decreased expression of AGTR1 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation |
ISO |
Aspartame results in increased phosphorylation of AKT1 protein |
CTD |
PMID:33992720 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ALOX15 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Apoe |
apolipoprotein E |
decreases expression |
ISO |
Aspartame results in decreased expression of APOE mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP ISO |
[Aspartame co-treated with Methotrexate] results in increased expression of BAX mRNA; [Aspartame co-treated with Methotrexate] results in increased expression of BAX protein Aspartame results in increased expression of BAX mRNA [Fats, Unsaturated co-treated with Aspartame] affects the expression of BAX mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of BAX mRNA |
CTD |
PMID:23783067 PMID:25009784 PMID:32951320 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP ISO |
[Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 mRNA; [Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 protein Aspartame results in decreased expression of BCL2 mRNA |
CTD |
PMID:25009784 PMID:32951320 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cabp2 |
calcium binding protein 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CABP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CABP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:201,374,649...201,380,469
Ensembl chr 1:201,375,276...201,380,469
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNA1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNA1I mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1I mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Cacna2d4 |
calcium voltage-gated channel auxiliary subunit alpha2delta 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNA2D4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA2D4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:152,408,588...152,521,478
Ensembl chr 4:152,408,657...152,521,268
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
|
|
G |
Cacng4 |
calcium voltage-gated channel auxiliary subunit gamma 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNG4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:92,683,778...92,745,842
Ensembl chr10:92,683,761...92,746,126
|
|
G |
Cacng8 |
calcium voltage-gated channel auxiliary subunit gamma 8 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNG8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG8 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:65,755,334...65,775,567
Ensembl chr 1:65,755,334...65,779,089
|
|
G |
Calhm2 |
calcium homeostasis modulator family member 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CALHM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALHM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:246,022,324...246,028,050
Ensembl chr 1:246,022,324...246,028,218
|
|
G |
Calr3 |
calreticulin 3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CALR3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALR3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr16:17,396,064...17,423,166
Ensembl chr16:17,396,247...17,423,015
|
|
G |
Cant1 |
calcium activated nucleotidase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CANT1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CANT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:103,637,079...103,650,240
Ensembl chr10:103,531,504...103,650,109
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
EXP ISO |
[Aspartame co-treated with Methotrexate] results in increased expression of CASP3 mRNA; [Aspartame co-treated with Methotrexate] results in increased expression of CASP3 protein modified form Aspartame results in increased expression of CASP3 mRNA |
CTD |
PMID:25009784 PMID:32951320 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CASP9 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CASP9 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
EXP ISO |
[Aspartame co-treated with Methotrexate] results in increased activity of CAT protein Aspartame results in decreased activity of CAT protein |
CTD |
PMID:25009784 PMID:32951320 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] results in increased expression of CCL2 protein; [Sodium Glutamate co-treated with Aspartame] inhibits the reaction [Fats, Unsaturated results in increased expression of CCL2 protein] |
CTD |
PMID:23783067 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression |
ISO |
Aspartame results in decreased expression of CDH1 protein |
CTD |
PMID:33992720 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
affects localization multiple interactions |
ISO |
Aspartame affects the localization of CDKN1A protein TAS1R1 protein affects the reaction [Aspartame affects the localization of CDKN1A protein] |
CTD |
PMID:33992720 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions decreases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CDKN1B mRNA Aspartame results in decreased expression of CDKN1B protein |
CTD |
PMID:23783067 PMID:33992720 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cherp |
calcium homeostasis endoplasmic reticulum protein |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CHERP mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CHERP mRNA |
CTD |
PMID:23783067 |
|
NCBI chr16:17,367,455...17,380,507
Ensembl chr16:17,367,455...17,380,507
|
|
G |
Cmc1 |
C-x(9)-C motif containing 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CMC1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CMC1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:117,798,036...117,900,458
Ensembl chr 8:117,798,945...117,900,462
|
|
G |
Cox11 |
cytochrome c oxidase copper chaperone COX11 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of COX11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX11 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:75,458,735...75,465,322
Ensembl chr10:75,458,749...75,465,322
|
|
G |
Cox7a1 |
cytochrome c oxidase subunit 7A1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of COX7A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX7A1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CPT1B mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1C mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:95,442,814...95,457,347
Ensembl chr 1:95,442,817...95,457,342
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CREB1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Csf1 |
colony stimulating factor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CSF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity |
EXP |
Aspartame results in increased activity of CYP1A1 protein |
CTD |
PMID:16937917 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity |
EXP |
Aspartame results in increased activity of CYP1A2 protein |
CTD |
PMID:16937917 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
Aspartame results in increased expression of and results in increased activity of CYP2B1 protein |
CTD |
PMID:16937917 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases activity |
EXP |
Aspartame results in increased activity of CYP2B2 protein |
CTD |
PMID:16937917 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
Aspartame results in increased expression of and results in increased activity of CYP2E1 protein |
CTD |
PMID:16937917 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
increases activity |
EXP |
Aspartame results in increased activity of CYP3A62 protein |
CTD |
PMID:16937917 |
|
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of DIABLO mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DIABLO mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dnajc27 |
DnaJ heat shock protein family (Hsp40) member C27 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of DNAJC27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DNAJC27 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:27,068,713...27,098,449
Ensembl chr 6:27,068,686...27,098,449
|
|
G |
E2f1 |
E2F transcription factor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of E2F1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of E2F1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Edn2 |
endothelin 2 |
decreases expression |
ISO |
Aspartame results in decreased expression of EDN2 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814
|
|
G |
Ednra |
endothelin receptor type A |
decreases expression |
ISO |
Aspartame results in decreased expression of EDNRA mRNA |
CTD |
PMID:31655124 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of EHHADH mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EHHADH mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of EPHX2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EPHX2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases activity |
ISO |
Aspartame analog results in decreased activity of F2 protein; Aspartame results in decreased activity of F2 protein |
CTD |
PMID:15572260 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
ISO |
Aspartame results in increased expression of FGF1 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of FOXO3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases expression |
ISO |
Aspartame results in decreased expression of FSHB protein |
CTD |
PMID:32951320 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GADD45B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gfm2 |
GTP dependent ribosome recycling factor mitochondrial 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of GFM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GFM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:28,449,452...28,488,200
Ensembl chr 2:28,449,517...28,488,197
|
|
G |
Gip |
gastric inhibitory polypeptide |
multiple interactions |
ISO |
Aspartame promotes the reaction [Fats, Unsaturated results in increased expression of GIP protein]; Sodium Glutamate inhibits the reaction [Aspartame promotes the reaction [Fats, Unsaturated results in increased expression of GIP protein]] |
CTD |
PMID:23783067 |
|
NCBI chr10:80,968,360...80,976,506
Ensembl chr10:80,968,352...80,976,503
|
|
G |
Gli1 |
GLI family zinc finger 1 |
affects localization multiple interactions |
ISO |
Aspartame affects the localization of GLI1 protein TAS1R1 protein affects the reaction [Aspartame affects the localization of GLI1 protein] |
CTD |
PMID:33992720 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gli2 |
GLI family zinc finger 2 |
decreases expression |
ISO |
Aspartame results in decreased expression of GLI2 protein |
CTD |
PMID:33992720 |
|
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases phosphorylation |
ISO |
Aspartame results in increased phosphorylation of GSK3B protein |
CTD |
PMID:33992720 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
[Aspartame co-treated with Methotrexate] results in decreased activity of GSR protein |
CTD |
PMID:25009784 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of HADHA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHA mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of HADHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac5 |
histone deacetylase 5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HGF mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases expression |
ISO |
Aspartame results in increased expression of HRAS |
CTD |
PMID:17354619 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hspg2 |
heparan sulfate proteoglycan 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HSPG2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:149,677,437...149,778,594
Ensembl chr 5:149,677,476...149,778,594
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of IDH2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IDH2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Il11 |
interleukin 11 |
decreases expression |
ISO |
Aspartame results in decreased expression of IL11 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
Aspartame results in increased expression of IL1B mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il3 |
interleukin 3 |
decreases expression |
ISO |
Aspartame results in decreased expression of IL3 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il6 |
interleukin 6 |
increases secretion |
ISO |
Aspartame results in increased secretion of IL6 protein |
CTD |
PMID:20837131 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Immt |
inner membrane mitochondrial protein |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of IMMT mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IMMT mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
|
|
G |
Ins2 |
insulin 2 |
increases expression multiple interactions |
ISO |
Aspartame results in increased expression of INS protein [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] results in increased expression of INS2 protein; Aspartame inhibits the reaction [Fats, Unsaturated results in increased expression of INS2 protein] |
CTD |
PMID:1805284 PMID:23783067 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Kdr |
kinase insert domain receptor |
increases secretion |
ISO |
Aspartame results in increased secretion of KDR protein |
CTD |
PMID:20837131 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Lep |
leptin |
decreases expression multiple interactions |
EXP ISO |
Aspartame results in decreased expression of LEP protein [Fats, Unsaturated co-treated with Aspartame] results in increased expression of LEP protein; [Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of LEP protein] |
CTD |
PMID:11890951 PMID:23783067 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression |
ISO |
Aspartame results in decreased expression of LHB protein |
CTD |
PMID:32951320 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lipg |
lipase G, endothelial type |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LIPG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
|
|
G |
Lrp2 |
LDL receptor related protein 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:54,189,305...54,346,769
Ensembl chr 3:54,189,308...54,346,708
|
|
G |
Lrp4 |
LDL receptor related protein 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:77,429,600...77,483,593
Ensembl chr 3:77,429,798...77,483,593
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
Aspartame results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:20837131 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
Aspartame results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:20837131 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mcu |
mitochondrial calcium uniporter |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MCU mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MCU mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:27,417,529...27,580,110
Ensembl chr20:27,417,526...27,580,110
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MDM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Med23 |
mediator complex subunit 23 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MED23 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:20,490,315...20,558,461
Ensembl chr 1:20,490,315...20,537,463
|
|
G |
Mef2d |
myocyte enhancer factor 2D |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MEF2D mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:173,606,054...173,635,620
Ensembl chr 2:173,606,490...173,634,457
|
|
G |
Micos10 |
mitochondrial contact site and cristae organizing system subunit 10 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MINOS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MINOS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:151,341,124...151,367,403
Ensembl chr 5:151,339,176...151,367,485
|
|
G |
Micu1 |
mitochondrial calcium uptake 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MICU1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MICU1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:27,668,681...27,816,322
Ensembl chr20:27,668,747...27,814,964
|
|
G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPL20 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL20 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492
|
|
G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPL3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:105,670,184...105,693,544
Ensembl chr 8:105,670,184...105,693,544
|
|
G |
Mrps12 |
mitochondrial ribosomal protein S12 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS12 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780
|
|
G |
Mrps24 |
mitochondrial ribosomal protein S24 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS24 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS24 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:80,584,671...80,588,801
Ensembl chr14:80,584,673...80,588,871
|
|
G |
Mrps27 |
mitochondrial ribosomal protein S27 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS27 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:30,740,007...30,808,577
Ensembl chr 2:30,740,033...30,808,577
|
|
G |
Mrps7 |
mitochondrial ribosomal protein S7 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS7 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:100,843,691...100,846,838
Ensembl chr10:100,843,356...100,847,129
|
|
G |
Mtfp1 |
mitochondrial fission process 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MTFP1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MTFP1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:78,968,434...78,972,274
Ensembl chr14:78,968,442...78,972,274
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
ISO |
Aspartame results in increased expression of MYC Aspartame results in increased expression of MYC protein |
CTD |
PMID:17354619 PMID:33992720 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NCOR1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
|
|
G |
Ndufa12 |
NADH:ubiquinone oxidoreductase subunit A12 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFA12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA12 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:28,771,330...28,798,316
Ensembl chr 7:28,771,330...28,798,315
|
|
G |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFA5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598 Ensembl chr 5:52,995,546...53,005,598
|
|
G |
Ndufb10 |
NADH:ubiquinone oxidoreductase subunit B10 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFB10 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB10 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:13,749,273...13,751,434
Ensembl chr10:13,749,275...13,751,442
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
|
|
G |
Ndufb6 |
NADH:ubiquinone oxidoreductase subunit B6 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFB6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB6 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:55,400,543...55,410,110
Ensembl chr 5:55,400,543...55,410,181
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Ndufs6 |
NADH:ubiquinone oxidoreductase subunit S6 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFS6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS6 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:29,968,833...29,977,423
Ensembl chr 1:29,968,842...29,977,467
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFV1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFV1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
|
|
G |
Nf1 |
neurofibromin 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
|
|
G |
Notch1 |
notch receptor 1 |
multiple interactions affects localization |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOTCH1 mRNA Aspartame affects the localization of NOTCH1 protein modified form TAS1R1 protein affects the reaction [Aspartame affects the localization of NOTCH1 protein modified form] |
CTD |
PMID:23783067 PMID:33992720 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOX1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Nppb |
natriuretic peptide B |
decreases expression |
ISO |
Aspartame results in decreased expression of NPPB mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Npy |
neuropeptide Y |
decreases expression |
EXP |
Aspartame results in decreased expression of NPY protein |
CTD |
PMID:11890951 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NR1I3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Onecut1 |
one cut homeobox 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ONECUT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:75,599,432...75,633,598
Ensembl chr 8:75,599,740...75,627,277
|
|
G |
Pdha2 |
pyruvate dehydrogenase E1 subunit alpha 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PDHA2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHA2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:229,872,300...229,873,848
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pex1 |
peroxisomal biogenesis factor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:30,519,950...30,558,953
Ensembl chr 4:30,519,955...30,558,921
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX11A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX11A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
|
|
G |
Pex13 |
peroxisomal biogenesis factor 13 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX13 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:97,602,829...97,621,233
Ensembl chr14:97,603,539...97,621,262
|
|
G |
Pex5 |
peroxisomal biogenesis factor 5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:157,270,671...157,296,432
Ensembl chr 4:157,270,672...157,296,431
|
|
G |
Pex7 |
peroxisomal biogenesis factor 7 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX7 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:14,582,698...14,646,686
Ensembl chr 1:14,582,699...14,646,748
|
|
G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PFKFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr13:42,147,473...42,174,699
Ensembl chr13:42,147,478...42,174,699
|
|
G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PFKFB4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
|
|
G |
Pld2 |
phospholipase D2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLD2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
|
|
G |
Plg |
plasminogen |
decreases expression |
ISO |
Aspartame results in decreased expression of PLG mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Plxnd1 |
plexin D1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLXND1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:149,002,786...149,043,097
Ensembl chr 4:149,002,784...149,043,244
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of POLG mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of POLG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
|
|
G |
Pomc |
proopiomelanocortin |
increases expression |
ISO |
Aspartame results in increased expression of POMC protein alternative form |
CTD |
PMID:1805284 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
affects localization |
ISO |
Aspartame affects the localization of POU5F1 protein |
CTD |
PMID:33992720 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PPARA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARA mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARD mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PPARGC1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARGC1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prdx5 |
peroxiredoxin 5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PRDX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PRDX5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ROCK1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
S100a13 |
S100 calcium binding protein A13 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of S100A13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A13 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:175,999,439...176,005,933
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of S100A8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A8 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SDHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Sirt2 |
sirtuin 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:84,053,883...84,076,975
Ensembl chr 1:84,052,903...84,076,975
|
|
G |
Slc15a1 |
solute carrier family 15 member 1 |
decreases activity |
ISO |
Aspartame results in decreased activity of SLC15A1 protein |
CTD |
PMID:15846457 |
|
NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545
|
|
G |
Slc4a2 |
solute carrier family 4 member 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC4A2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:10,736,419...10,754,407
Ensembl chr 4:10,736,425...10,752,965
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SLC8A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC8A1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
affects localization |
ISO |
Aspartame affects the localization of SOX2 protein |
CTD |
PMID:33992720 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SREBF2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of STAT3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Surf1 |
SURF1, cytochrome c oxidase assembly factor |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SURF1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SURF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:10,241,793...10,244,686
Ensembl chr 3:10,241,837...10,263,315
|
|
G |
Tas1r1 |
taste 1 receptor member 1 |
increases expression multiple interactions |
ISO |
Aspartame results in increased expression of TAS1R1 protein Aspartame promotes the reaction [TAS1R3 protein binds to TAS1R1 protein]; TAS1R1 protein affects the reaction [Aspartame affects the localization of CDKN1A protein]; TAS1R1 protein affects the reaction [Aspartame affects the localization of GLI1 protein]; TAS1R1 protein affects the reaction [Aspartame affects the localization of NOTCH1 protein modified form] |
CTD |
PMID:33992720 |
|
NCBI chr 5:162,533,838...162,546,408
Ensembl chr 5:162,533,841...162,545,562
|
|
G |
Tas1r2 |
taste 1 receptor member 2 |
multiple interactions affects binding |
ISO |
Aspartame binds to and results in increased activity of TAS1R2 protein; Aspartame promotes the reaction [TAS1R3 protein binds to TAS1R2 protein]; lactisole inhibits the reaction [Aspartame results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]] Aspartame binds to [TAS1R2 protein binds to TAS1R3 protein]; Aspartame binds to TAS1R2 protein |
CTD |
PMID:15353592 PMID:17168764 PMID:17935609 PMID:20173092 PMID:33992720 |
|
NCBI chr 5:151,909,617...151,925,760
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Tas1r3 |
taste 1 receptor member 3 |
affects binding decreases expression multiple interactions |
ISO |
Aspartame binds to [TAS1R2 protein binds to TAS1R3 protein] Aspartame results in decreased expression of TAS1R3 protein Aspartame promotes the reaction [TAS1R3 protein binds to TAS1R1 protein]; Aspartame promotes the reaction [TAS1R3 protein binds to TAS1R2 protein]; lactisole inhibits the reaction [Aspartame results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]] |
CTD |
PMID:17168764 PMID:17935609 PMID:33992720 |
|
NCBI chr 5:166,468,703...166,472,759
Ensembl chr 5:166,469,589...166,472,742
|
|
G |
Tfam |
transcription factor A, mitochondrial |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of TFAM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TFAM mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Thbs1 |
thrombospondin 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of THBS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] results in increased expression of TNF protein; [Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of TNF protein] |
CTD |
PMID:23783067 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
Aspartame results in increased expression of TRP53; Aspartame results in increased expression of TRP53 mRNA [Fats, Unsaturated co-treated with Aspartame] affects the expression of TRP53 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TRP53 mRNA |
CTD |
PMID:17354619 PMID:23783067 PMID:32951320 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
increases activity |
ISO |
Aspartame results in increased activity of TRPV1 protein |
CTD |
PMID:17567713 PMID:18804451 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of TUFM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TUFM mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:181,073,788...181,077,395
Ensembl chr 1:181,073,788...181,077,395
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of UCP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UCP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of UQCR11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UQCR11 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases secretion |
ISO |
Aspartame results in increased secretion of VEGFA protein |
CTD |
PMID:20837131 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
increases expression |
ISO |
Aspartame results in increased expression of VIM protein |
CTD |
PMID:33992720 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of XDH mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
affects localization |
ISO |
citraconic acid affects the localization of BACH1 protein |
CTD |
PMID:27277809 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Foxm1 |
forkhead box M1 |
increases expression |
ISO |
citraconic acid results in increased expression of FOXM1 protein |
CTD |
PMID:28289076 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
citraconic acid results in increased expression of FTH1 protein |
CTD |
PMID:28289076 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
multiple interactions increases expression |
ISO |
citraconic acid promotes the reaction [NFE2L2 protein results in increased expression of FTL protein]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of FTL protein] |
CTD |
PMID:28289076 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
EXP ISO |
citraconic acid results in increased expression of GCLC protein citraconic acid results in increased expression of GCLC mRNA |
CTD |
PMID:27277809 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
EXP ISO |
citraconic acid results in increased expression of GCLM protein citraconic acid results in increased expression of GCLM mRNA |
CTD |
PMID:27277809 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO EXP |
citraconic acid results in increased expression of GSR mRNA citraconic acid results in increased expression of GSR protein |
CTD |
PMID:27277809 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
multiple interactions |
ISO |
citraconic acid binds to and results in increased activity of HCAR2 protein |
CTD |
PMID:18722346 |
|
NCBI chr12:32,726,252...32,728,238
Ensembl chr12:32,726,184...32,728,504
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP ISO |
citraconic acid results in increased expression of HMOX1 mRNA; citraconic acid results in increased expression of HMOX1 protein |
CTD |
PMID:27277809 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [citraconic acid results in increased expression of CYTB mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
increases expression multiple interactions |
ISO |
citraconic acid results in increased expression of ND1 mRNA NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND1 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:2,740...3,694
|
|
G |
Mt-nd5 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 |
increases expression multiple interactions |
ISO |
citraconic acid results in increased expression of ND5 mRNA NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND5 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
|
|
G |
Mt-nd6 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND6 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions affects localization |
ISO |
NFE2L2 protein affects the reaction [citraconic acid results in increased expression of CYTB mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND1 mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND5 mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND6 mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of POLRMT mRNA] citraconic acid promotes the reaction [NFE2L2 protein results in increased expression of FTL protein]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of FTL protein] citraconic acid affects the localization of NFE2L2 protein |
CTD |
PMID:27277809 PMID:28289076 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
EXP |
citraconic acid results in increased expression of NQO1 mRNA; citraconic acid results in increased expression of NQO1 protein |
CTD |
PMID:27277809 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Polrmt |
RNA polymerase mitochondrial |
increases expression multiple interactions |
ISO |
citraconic acid results in increased expression of POLRMT mRNA NFE2L2 protein affects the reaction [citraconic acid results in increased expression of POLRMT mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr 7:9,959,532...9,969,791
Ensembl chr 7:9,959,576...9,969,791
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation |
ISO EXP |
D-Aspartic Acid results in increased phosphorylation of AKT1 protein |
CTD |
PMID:26189884 PMID:31398714 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Ar |
androgen receptor |
affects expression increases expression |
EXP |
D-Aspartic Acid affects the expression of AR mRNA D-Aspartic Acid results in increased expression of AR protein |
CTD |
PMID:24439162 PMID:26044185 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Aurkb |
aurora kinase B |
increases expression |
ISO |
D-Aspartic Acid results in increased expression of AURKB protein |
CTD |
PMID:26189884 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
D-Aspartic Acid results in increased activity of and results in increased cleavage of CASP3 protein; Dizocilpine Maleate inhibits the reaction [D-Aspartic Acid results in increased activity of and results in increased cleavage of CASP3 protein] |
CTD |
PMID:30822420 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cln8 |
CLN8, transmembrane ER and ERGIC protein |
multiple interactions affects export |
ISO |
CLN8 protein affects the reaction [[Ionomycin co-treated with Calcium] results in increased transport of D-Aspartic Acid]; CLN8 protein affects the reaction [[Potassium Chloride co-treated with Calcium] results in increased transport of D-Aspartic Acid] CLN8 protein affects the export of D-Aspartic Acid |
CTD |
PMID:22302580 |
|
NCBI chr16:74,749,662...74,759,553
Ensembl chr16:74,749,662...74,759,774
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
increases expression |
EXP |
D-Aspartic Acid results in increased expression of CYP11A1 mRNA |
CTD |
PMID:24713504 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression decreases expression |
ISO EXP |
D-Aspartic Acid results in increased expression of CYP19A1 mRNA; D-Aspartic Acid results in increased expression of CYP19A1 protein D-Aspartic Acid results in decreased expression of CYP19A1 protein |
CTD |
PMID:24439162 PMID:26044185 PMID:26189884 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Ddo |
D-aspartate oxidase |
affects abundance increases metabolic processing increases degradation |
ISO EXP |
DDO protein affects the abundance of D-Aspartic Acid DDO protein results in increased metabolism of D-Aspartic Acid DDO protein results in increased degradation of D-Aspartic Acid |
CTD |
PMID:16516413 PMID:16525061 PMID:16725213 PMID:18842900 PMID:26961959 PMID:32185508 PMID:32376478 More...
|
|
NCBI chr20:44,090,823...44,109,962
Ensembl chr20:44,090,914...44,133,095
|
|
G |
Esr1 |
estrogen receptor 1 |
increases expression decreases expression |
EXP |
D-Aspartic Acid results in increased expression of ESR1 mRNA D-Aspartic Acid results in decreased expression of ESR1 protein |
CTD |
PMID:24439162 PMID:26044185 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases expression |
ISO |
D-Aspartic Acid results in increased expression of ESR2 protein |
CTD |
PMID:26189884 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
increases expression |
EXP |
D-Aspartic Acid results in increased expression of GRIN1 mRNA |
CTD |
PMID:24439162 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
increases expression |
EXP |
D-Aspartic Acid results in increased expression of GRIN2A mRNA |
CTD |
PMID:24439162 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
affects metabolic processing |
ISO |
ITPR3 mutant form affects the metabolism of D-Aspartic Acid |
CTD |
PMID:32853769 |
|
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
|
|
G |
Lhb |
luteinizing hormone subunit beta |
increases expression |
EXP |
D-Aspartic Acid results in increased expression of LHB protein |
CTD |
PMID:24713504 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
EXP ISO |
D-Aspartic Acid results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:24439162 PMID:26189884 PMID:31398714 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO EXP |
D-Aspartic Acid results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:24439162 PMID:26189884 PMID:31398714 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions increases cleavage |
EXP |
D-Aspartic Acid results in decreased expression of and affects the phosphorylation of MAPT protein; Dizocilpine Maleate inhibits the reaction [D-Aspartic Acid results in decreased expression of and affects the phosphorylation of MAPT protein]; Dizocilpine Maleate inhibits the reaction [D-Aspartic Acid results in decreased phosphorylation of MAPT protein]; Dizocilpine Maleate inhibits the reaction [D-Aspartic Acid results in increased cleavage of MAPT protein] |
CTD |
PMID:30822420 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
ISO |
D-Aspartic Acid results in increased expression of PCNA protein |
CTD |
PMID:26189884 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Prep |
prolyl endopeptidase |
increases expression |
EXP |
D-Aspartic Acid results in increased expression of PREP protein |
CTD |
PMID:31398714 |
|
NCBI chr20:48,556,211...48,653,165
Ensembl chr20:48,556,280...48,654,466
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
SOD1 protein affects the reaction [Glycine results in increased secretion of D-Aspartic Acid] |
CTD |
PMID:12684256 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
increases expression |
EXP |
D-Aspartic Acid results in increased expression of SRD5A1 mRNA |
CTD |
PMID:26044185 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
increases expression |
EXP |
D-Aspartic Acid results in increased expression of SRD5A2 mRNA |
CTD |
PMID:26044185 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Srr |
serine racemase |
increases abundance multiple interactions |
EXP ISO |
SRR protein results in increased abundance of D-Aspartic Acid [SRR protein results in increased metabolism of Aspartic Acid] which results in increased abundance of D-Aspartic Acid; Adenosine Triphosphate inhibits the reaction [Edetic Acid inhibits the reaction [SRR protein results in increased abundance of D-Aspartic Acid]]; Adenosine Triphosphate promotes the reaction [SRR protein results in increased abundance of D-Aspartic Acid]; Edetic Acid inhibits the reaction [SRR protein results in increased abundance of D-Aspartic Acid]; Hydroxylamine inhibits the reaction [SRR protein results in increased abundance of D-Aspartic Acid]; Pyridoxal Phosphate inhibits the reaction [Hydroxylamine inhibits the reaction [SRR protein results in increased abundance of D-Aspartic Acid]] |
CTD |
PMID:27387750 |
|
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
|
|
G |
Star |
steroidogenic acute regulatory protein |
increases expression |
EXP |
D-Aspartic Acid results in increased expression of STAR mRNA; D-Aspartic Acid results in increased expression of STAR protein |
CTD |
PMID:24713504 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
|
G |
Casp3 |
caspase 3 |
increases cleavage |
ISO |
diethyl fumarate results in increased cleavage of CASP3 protein |
CTD |
PMID:21105742 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
diethyl fumarate results in increased cleavage of PARP1 protein |
CTD |
PMID:21105742 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
increases cleavage |
ISO |
diethyl fumarate results in increased cleavage of SPTAN1 protein |
CTD |
PMID:21105742 |
|
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
affects expression |
ISO |
diethyl malate affects the expression of ACTA2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actc1 |
actin, alpha, cardiac muscle 1 |
affects expression |
ISO |
diethyl malate affects the expression of ACTC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:100,811,987...100,817,523
Ensembl chr 3:100,811,987...100,817,523
|
|
G |
Actn3 |
actinin alpha 3 |
affects expression |
ISO |
diethyl malate affects the expression of ACTN3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:202,159,081...202,175,012
Ensembl chr 1:202,159,082...202,175,012
|
|
G |
Adcy1 |
adenylate cyclase 1 |
affects expression |
ISO |
diethyl malate affects the expression of ADCY1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:81,911,240...82,020,594
Ensembl chr14:81,911,099...82,028,969
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
affects expression |
ISO |
diethyl malate affects the expression of ADH1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Agt |
angiotensinogen |
affects expression |
ISO |
diethyl malate affects the expression of AGT mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
ISO |
diethyl malate results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
increases expression |
ISO |
diethyl malate results in increased expression of ASF1B mRNA |
CTD |
PMID:38498338 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Atp6v1b2 |
ATPase H+ transporting V1 subunit B2 |
increases expression |
ISO |
diethyl malate results in increased expression of ATP6V1B2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr16:20,617,515...20,641,651
Ensembl chr16:20,617,518...20,641,745
|
|
G |
Bag3 |
BAG cochaperone 3 |
increases expression |
ISO |
diethyl malate results in increased expression of BAG3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bcas2 |
BCAS2, pre-mRNA processing factor |
increases expression |
ISO |
diethyl malate results in increased expression of BCAS2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 2:190,692,503...190,700,386
Ensembl chr 2:190,692,461...190,700,389
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
ISO |
diethyl malate results in increased expression of BCL2L11 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Brd2 |
bromodomain containing 2 |
increases expression |
ISO |
diethyl malate results in increased expression of BRD2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
C3 |
complement C3 |
affects expression |
ISO |
diethyl malate affects the expression of C3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
affects expression |
ISO |
diethyl malate affects the expression of CACNB2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
|
|
G |
Cacnb4 |
calcium voltage-gated channel auxiliary subunit beta 4 |
affects expression |
ISO |
diethyl malate affects the expression of CACNB4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:36,906,771...37,169,165
Ensembl chr 3:36,910,427...37,168,944
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of CAMK2A mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Casp3 |
caspase 3 |
increases expression |
ISO |
diethyl malate results in increased expression of CASP3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cbr2 |
carbonyl reductase 2 |
affects expression |
ISO |
diethyl malate affects the expression of CBR2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:106,008,535...106,012,838
Ensembl chr10:105,991,589...106,013,001
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
affects expression increases expression |
ISO |
diethyl malate affects the expression of CCL20 mRNA diethyl malate results in increased expression of CCL20 mRNA |
CTD |
PMID:24814887 PMID:38498338 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
affects expression |
ISO |
diethyl malate affects the expression of CCL7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
affects expression |
ISO |
diethyl malate affects the expression of CCL6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
ISO |
diethyl malate results in increased expression of CTGF mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccne2 |
cyclin E2 |
increases expression |
ISO |
diethyl malate results in increased expression of CCNE2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
increases expression |
ISO |
diethyl malate results in increased expression of CDK5R1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of CHAC1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
increases expression |
ISO |
diethyl malate results in increased expression of CIDEC mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
ISO |
diethyl malate results in increased expression of CKS2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clk1 |
CDC-like kinase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of CLK1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:59,947,764...59,957,000
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL11A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL2A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL3A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL6A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Comp |
cartilage oligomeric matrix protein |
affects expression |
ISO |
diethyl malate affects the expression of COMP mRNA |
CTD |
PMID:24814887 |
|
NCBI chr16:19,047,206...19,055,584
Ensembl chr16:19,047,207...19,055,845
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
increases expression |
ISO |
diethyl malate results in increased expression of CSRNP1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of CXCL12 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of CXCL12 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
affects expression |
ISO |
diethyl malate affects the expression of CXCL1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
affects expression |
ISO |
diethyl malate affects the expression of CYP2J9 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
increases expression |
ISO |
diethyl malate results in increased expression of CYP4F3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
|
|
G |
Dapk2 |
death-associated protein kinase 2 |
affects expression |
ISO |
diethyl malate affects the expression of DAPK2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:66,706,536...66,825,567
Ensembl chr 8:66,706,609...66,825,567
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
diethyl malate results in increased expression of DDIT3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
affects expression |
ISO |
diethyl malate affects the expression of DHRS3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
affects expression |
ISO |
diethyl malate affects the expression of DHX58 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
diethyl malate results in increased expression of DNAJB4 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Edar |
ectodysplasin-A receptor |
affects expression |
ISO |
diethyl malate affects the expression of EDAR mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:26,587,836...26,666,543
Ensembl chr20:26,587,839...26,666,494
|
|
G |
Ednra |
endothelin receptor type A |
affects expression |
ISO |
diethyl malate affects the expression of EDNRA mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Emg1 |
EMG1 N1-specific pseudouridine methyltransferase |
increases expression |
ISO |
diethyl malate results in increased expression of EMG1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 4:157,509,258...157,517,540
Ensembl chr 4:157,509,277...157,517,540
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
diethyl malate results in increased expression of ENO2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
affects expression |
ISO |
diethyl malate affects the expression of EPAS1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epha7 |
Eph receptor A7 |
affects expression |
ISO |
diethyl malate affects the expression of EPHA7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112
|
|
G |
Ephb2 |
Eph receptor B2 |
affects expression |
ISO |
diethyl malate affects the expression of EPHB2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Ephb6 |
Eph receptor B6 |
affects expression |
ISO |
diethyl malate affects the expression of EPHB6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
increases expression |
ISO |
diethyl malate results in increased expression of FAM83D mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects expression |
ISO |
diethyl malate affects the expression of FGF10 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of FGF18 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects expression |
ISO |
diethyl malate affects the expression of FGFR2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
diethyl malate results in increased expression of FOSL1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Fst |
follistatin |
affects expression |
ISO |
diethyl malate affects the expression of FST mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Fzd2 |
frizzled class receptor 2 |
affects expression |
ISO |
diethyl malate affects the expression of FZD2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
|
|
G |
Fzd7 |
frizzled class receptor 7 |
affects expression |
ISO |
diethyl malate affects the expression of FZD7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
ISO |
diethyl malate results in increased expression of G6PD mRNA |
CTD |
PMID:38498338 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects expression |
ISO |
diethyl malate affects the expression of GCLC mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GCLM mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
diethyl malate results in increased expression of GCNT3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Ggt6 |
gamma-glutamyl transferase 6 |
affects expression |
ISO |
diethyl malate affects the expression of GGT6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:57,051,977...57,054,900
Ensembl chr10:57,051,825...57,067,260
|
|
G |
Gli2 |
GLI family zinc finger 2 |
affects expression |
ISO |
diethyl malate affects the expression of GLI2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Gnao1 |
G protein subunit alpha o1 |
affects expression |
ISO |
diethyl malate affects the expression of GNAO1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493
|
|
G |
Gng7 |
G protein subunit gamma 7 |
affects expression |
ISO |
diethyl malate affects the expression of GNG7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
|
|
G |
Gnpda1 |
glucosamine-6-phosphate deaminase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of GNPDA1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr18:30,165,435...30,177,462
Ensembl chr18:30,165,427...30,177,486
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
ISO |
diethyl malate results in increased expression of GPAT3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gsr |
glutathione-disulfide reductase |
affects expression |
ISO |
diethyl malate affects the expression of GSR mRNA |
CTD |
PMID:24814887 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSS mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
affects expression |
ISO |
diethyl malate affects the expression of GUCY1A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
affects expression |
ISO |
diethyl malate affects the expression of GUCY1B1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
H2ac4 |
H2A clustered histone 4 |
increases expression |
ISO |
diethyl malate results in increased expression of HIST1H2AC mRNA |
CTD |
PMID:38498338 |
|
NCBI chr17:42,799,884...42,800,387
Ensembl chr17:42,799,652...42,800,381
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
affects expression |
ISO |
diethyl malate affects the expression of HCK mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hgf |
hepatocyte growth factor |
affects expression |
ISO |
diethyl malate affects the expression of HGF mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hist1h2bd |
histone cluster 1 H2B family member D |
increases expression |
ISO |
diethyl malate results in increased expression of HIST1H2BD mRNA |
CTD |
PMID:38498338 |
|
NCBI chr17:42,792,887...42,793,268
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
increases expression |
ISO |
diethyl malate results in increased expression of HMGCS2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
increases expression |
ISO |
diethyl malate results in increased expression of HMMR mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of HMOX1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
ISO |
diethyl malate results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
diethyl malate results in increased expression of HSPA1A mRNA |
CTD |
PMID:38498338 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
diethyl malate results in increased expression of HSPA1B mRNA |
CTD |
PMID:38498338 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
increases expression |
ISO |
diethyl malate results in increased expression of HSPA2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
ISO |
diethyl malate results in increased expression of HSPA8 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
increases expression |
ISO |
diethyl malate results in increased expression of IFRD1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Igf1 |
insulin-like growth factor 1 |
affects expression |
ISO |
diethyl malate affects the expression of IGF1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
increases expression |
ISO |
diethyl malate results in increased expression of IGFBP3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Il15 |
interleukin 15 |
affects expression |
ISO |
diethyl malate affects the expression of IL15 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il18 |
interleukin 18 |
affects expression |
ISO |
diethyl malate affects the expression of IL18 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Irag1 |
inositol 1,4,5-triphosphate receptor associated 1 |
affects expression |
ISO |
diethyl malate affects the expression of IRAG1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:164,981,716...165,094,232
Ensembl chr 1:164,981,716...165,094,176
|
|
G |
Irf7 |
interferon regulatory factor 7 |
affects expression |
ISO |
diethyl malate affects the expression of IRF7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
affects expression |
ISO |
diethyl malate affects the expression of ISG15 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Itga11 |
integrin subunit alpha 11 |
affects expression |
ISO |
diethyl malate affects the expression of ITGA11 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:63,145,998...63,254,714
Ensembl chr 8:63,146,001...63,254,407
|
|
G |
Itga3 |
integrin subunit alpha 3 |
affects expression |
ISO |
diethyl malate affects the expression of ITGA3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Jmjd6 |
jumonji domain containing 6, arginine demethylase and lysine hydroxylase |
increases expression |
ISO |
diethyl malate results in increased expression of JMJD6 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
|
|
G |
Kcnmb4 |
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
affects expression |
ISO |
diethyl malate affects the expression of KCNMB4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:52,066,145...52,119,098
Ensembl chr 7:52,066,136...52,119,278
|
|
G |
Lama1 |
laminin subunit alpha 1 |
affects expression |
ISO |
diethyl malate affects the expression of LAMA1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:107,692,770...107,816,847
Ensembl chr 9:107,692,770...107,817,478
|
|
G |
Lama4 |
laminin subunit alpha 4 |
affects expression |
ISO |
diethyl malate affects the expression of LAMA4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
diethyl malate results in increased expression of MAFF mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
diethyl malate results in increased expression of MAFG mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
ISO |
diethyl malate results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:38498338 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
affects phosphorylation multiple interactions |
ISO |
diethyl malate affects the phosphorylation of MAPK1 protein S-ethyl glutathione inhibits the reaction [diethyl malate affects the phosphorylation of MAPK1 protein] |
CTD |
PMID:24814887 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
affects phosphorylation multiple interactions |
ISO |
diethyl malate affects the phosphorylation of MAPK3 protein S-ethyl glutathione inhibits the reaction [diethyl malate affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:24814887 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of MMP1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
diethyl malate results in increased expression of MMP3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Myl4 |
myosin, light chain 4 |
increases expression |
ISO |
diethyl malate results in increased expression of MYL4 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:89,449,456...89,485,365
Ensembl chr10:89,449,443...89,485,363
|
|
G |
Myl9 |
myosin light chain 9 |
affects expression |
ISO |
diethyl malate affects the expression of MYL9 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
increases expression |
ISO |
diethyl malate results in increased expression of NDRG1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
affects expression |
ISO |
diethyl malate affects the expression of ODC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
increases expression |
ISO |
diethyl malate results in increased expression of OSGIN1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of PDGFB mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of PDGFB mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfd |
platelet derived growth factor D |
affects expression |
ISO |
diethyl malate affects the expression of PDGFD mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
|
|
G |
Pf4 |
platelet factor 4 |
affects expression |
ISO |
diethyl malate affects the expression of PF4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
|
|
G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
increases expression |
ISO |
diethyl malate results in increased expression of PFKFB4 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
|
|
G |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
affects expression |
ISO |
diethyl malate affects the expression of PIK3IP1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:78,204,668...78,216,616
Ensembl chr14:78,204,053...78,216,608
|
|
G |
Plin2 |
perilipin 2 |
increases expression |
ISO |
diethyl malate results in increased expression of PLIN2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plxnc1 |
plexin C1 |
affects expression |
ISO |
diethyl malate affects the expression of PLXNC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:29,390,048...29,543,779
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
diethyl malate results in increased expression of PPP1R15A mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
affects expression |
ISO |
diethyl malate affects the expression of PRKG1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Ptgis |
prostaglandin I2 synthase |
affects expression |
ISO |
diethyl malate affects the expression of PTGIS mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
affects expression |
ISO |
diethyl malate affects the expression of RAMP2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
|
|
G |
Rgs3 |
regulator of G-protein signaling 3 |
affects expression |
ISO |
diethyl malate affects the expression of RGS3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894
|
|
G |
Rig1 |
RNA sensor RIG-1 |
affects expression |
ISO |
diethyl malate affects the expression of RIGI mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
|
|
G |
RT1-DMb |
RT1 class II, locus DMb |
affects expression |
ISO |
diethyl malate affects the expression of H2-DMB1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
|
|
G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
affects expression |
ISO |
diethyl malate affects the expression of H2-M3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
|
|
G |
Runx1t1 |
RUNX1 partner transcriptional co-repressor 1 |
affects expression |
ISO |
diethyl malate affects the expression of RUNX1T1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592
|
|
G |
Sema3b |
semaphorin 3B |
affects expression |
ISO |
diethyl malate affects the expression of SEMA3B mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:108,271,663...108,280,326
Ensembl chr 8:108,271,666...108,282,919
|
|
G |
Sema4g |
semaphorin 4G |
affects expression |
ISO |
diethyl malate affects the expression of SEMA4G mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:243,849,979...243,865,343
Ensembl chr 1:243,853,854...243,865,341
|
|
G |
Sema5a |
semaphorin 5A |
affects expression |
ISO |
diethyl malate affects the expression of SEMA5A mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:83,309,843...83,741,084
Ensembl chr 2:83,309,843...83,741,084
|
|
G |
Sertad1 |
SERTA domain containing 1 |
increases expression |
ISO |
diethyl malate results in increased expression of SERTAD1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
diethyl malate results in increased expression of SLC7A11 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
diethyl malate results in increased expression of SRXN1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
affects expression |
ISO |
diethyl malate affects the expression of STAT1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Tacc3 |
transforming, acidic coiled-coil containing protein 3 |
increases expression |
ISO |
diethyl malate results in increased expression of TACC3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219
|
|
G |
Tes |
testin LIM domain protein |
increases expression |
ISO |
diethyl malate results in increased expression of TES mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 4:45,365,304...45,403,829
Ensembl chr 4:45,365,285...45,403,829
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of TGFB2 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of TGFB2 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Thbs1 |
thrombospondin 1 |
affects expression |
ISO |
diethyl malate affects the expression of THBS1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thbs2 |
thrombospondin 2 |
affects expression |
ISO |
diethyl malate affects the expression of THBS2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:55,670,394...55,699,789
Ensembl chr 1:55,670,394...55,699,789
|
|
G |
Tnc |
tenascin C |
affects expression |
ISO |
diethyl malate affects the expression of TNC mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
affects expression |
ISO |
diethyl malate affects the expression of TNFRSF11B mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnnt1 |
troponin T1, slow skeletal type |
affects expression |
ISO |
diethyl malate affects the expression of TNNT1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:69,306,362...69,316,721
Ensembl chr 1:69,306,362...69,316,721
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
ISO |
diethyl malate results in increased expression of TRIB3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Tslp |
thymic stromal lymphopoietin |
affects expression |
ISO |
diethyl malate affects the expression of TSLP mRNA |
CTD |
PMID:24814887 |
|
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
diethyl malate results in increased expression of VEGFA mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Zbtb21 |
zinc finger and BTB domain containing 21 |
increases expression |
ISO |
diethyl malate results in increased expression of ZBTB21 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr11:37,312,337...37,327,040
Ensembl chr11:37,312,378...37,326,996
|
|
G |
Zfp110 |
zinc finger protein 110 |
increases expression |
ISO |
diethyl malate results in increased expression of ZNF274 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:73,445,303...73,461,112
Ensembl chr 1:73,445,336...73,461,086
|
|
G |
Zfp367 |
zinc finger protein 367 |
increases expression |
ISO |
diethyl malate results in increased expression of ZNF367 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr17:965,161...984,290
Ensembl chr17:965,161...984,287
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of ABCC2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
diethyl maleate results in increased expression of ABHD4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ACACA mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
multiple interactions |
EXP |
diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]; resveratrol inhibits the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]]; resveratrol promotes the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]] |
CTD |
PMID:17134953 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acy3 |
aminoacylase 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ACY3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
|
|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
diethyl maleate results in increased expression of ADM mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora3 |
adenosine A3 receptor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ADORA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:193,352,759...193,392,946
Ensembl chr 2:193,388,713...193,392,357
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
ISO |
diethyl maleate results in increased expression of AEN mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Afp |
alpha-fetoprotein |
increases expression |
ISO |
diethyl maleate results in increased expression of AFP mRNA |
CTD |
PMID:25270620 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Ahcyl1 |
adenosylhomocysteinase-like 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of AHCYL1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:195,294,149...195,328,586
Ensembl chr 2:195,294,153...195,345,815
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
increases expression |
EXP |
diethyl maleate results in increased expression of AKR1A1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
diethyl maleate results in increased expression of AKR1B10 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
diethyl maleate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
affects reduction |
ISO |
diethyl maleate affects the reduction of ALDH1A1 protein |
CTD |
PMID:19843705 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ALDH1B1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
decreases reduction increases expression decreases expression |
ISO EXP |
diethyl maleate results in decreased reduction of ALDH2 protein diethyl maleate results in increased expression of ALDH2 protein diethyl maleate results in decreased expression of ALDH2 protein |
CTD |
PMID:19843705 PMID:21161181 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
affects expression |
ISO |
diethyl maleate affects the expression of ALDOA mRNA |
CTD |
PMID:34480604 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ALDOB protein |
CTD |
PMID:21161181 |
|
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Angptl2 |
angiopoietin-like 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ANGPTL2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
ISO |
diethyl maleate results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ANKRD46 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:67,647,202...67,668,180
Ensembl chr 7:67,647,204...67,668,132
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
EXP |
diethyl maleate results in increased expression of ANLN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Anxa1 |
annexin A1 |
affects expression |
ISO |
diethyl maleate affects the expression of ANXA1 mRNA |
CTD |
PMID:34480604 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa3 |
annexin A3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ANXA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Ap3m2 |
adaptor related protein complex 3 subunit mu 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of AP3M2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:69,217,526...69,237,372
Ensembl chr16:69,217,633...69,235,431
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of APAF1 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Aplp1 |
amyloid beta precursor like protein 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of APLP1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:85,696,880...85,707,215
Ensembl chr 1:85,696,882...85,707,155
|
|
G |
Apol9a |
apolipoprotein L9a |
decreases expression |
EXP |
diethyl maleate results in decreased expression of APOL9A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
|
|
G |
Arhgap9 |
Rho GTPase activating protein 9 |
increases expression |
ISO |
diethyl maleate results in increased expression of ARHGAP9 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 7:63,148,573...63,157,025
Ensembl chr 7:63,148,900...63,157,524
|
|
G |
Arrdc2 |
arrestin domain containing 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ARRDC2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:18,601,897...18,606,029
Ensembl chr16:18,601,897...18,606,029
|
|
G |
Arrdc4 |
arrestin domain containing 4 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ARRDC4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
increases expression |
EXP |
diethyl maleate results in increased expression of ASF1B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ASXL1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
|
|
G |
Atm |
ATM serine/threonine kinase |
increases expression |
ISO |
diethyl maleate results in increased expression of ATM mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
increases expression |
EXP |
diethyl maleate results in increased expression of ATP5F1B protein |
CTD |
PMID:21161181 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Aurka |
aurora kinase A |
increases expression decreases expression |
EXP ISO |
diethyl maleate results in increased expression of AURKA mRNA diethyl maleate results in decreased expression of AURKA mRNA |
CTD |
PMID:21161181 PMID:25270620 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
diethyl maleate results in increased expression of BBC3 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
ISO |
[diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of BCL2 mRNA diethyl maleate results in increased expression of BCL2 mRNA |
CTD |
PMID:22564015 PMID:33545341 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BCL2A1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
decreases expression |
ISO |
diethyl maleate results in decreased expression of BCL3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
|
|
G |
Bcl6b |
BCL6B, transcription repressor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BCL6B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BHLHE41 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BHMT mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [TNF protein results in increased expression of BIRC3 mRNA] |
CTD |
PMID:12774022 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
diethyl maleate results in increased expression of BLVRB mRNA |
CTD |
PMID:25270620 PMID:34626751 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmf |
Bcl2 modifying factor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BMF mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Brip1 |
BRCA1 interacting DNA helicase 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of BRIP1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
Btbd2 |
BTB domain containing 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BTBD2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:9,058,609...9,075,341
Ensembl chr 7:9,060,788...9,075,344
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression decreases expression multiple interactions |
ISO |
diethyl maleate results in increased expression of BTG2 mRNA diethyl maleate results in decreased expression of BTG2 mRNA NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA]; TRP53 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA] |
CTD |
PMID:22003191 PMID:25270620 PMID:34626751 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
C6 |
complement C6 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of C6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
|
|
G |
Casp2 |
caspase 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of CASP2 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases expression increases cleavage |
ISO |
diethyl maleate results in increased expression of CASP3 mRNA diethyl maleate results in increased cleavage of CASP3 protein |
CTD |
PMID:11875189 PMID:21105742 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
diethyl maleate results in increased expression of CASP9 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CAT protein |
CTD |
PMID:21161181 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr1 |
carbonyl reductase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of CBR1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression multiple interactions |
ISO |
diethyl maleate results in increased expression of CBR3 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diethyl maleate results in increased expression of CBR3 mRNA] |
CTD |
PMID:20806931 PMID:25270620 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Cbx4 |
chromobox 4 |
increases expression |
ISO |
diethyl maleate results in increased expression of CBX4 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr10:104,337,140...104,343,210
Ensembl chr10:104,336,876...104,356,706
|
|
G |
Ccdc50 |
coiled-coil domain containing 50 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CCDC50 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:73,332,798...73,395,333
Ensembl chr11:73,334,248...73,395,150
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CCNA1 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
EXP |
diethyl maleate results in increased expression of CCNA2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression increases expression |
ISO EXP |
diethyl maleate results in decreased expression of CCND1 mRNA diethyl maleate results in increased expression of CCND1 mRNA |
CTD |
PMID:11875189 PMID:21161181 PMID:25270620 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne2 |
cyclin E2 |
increases expression |
EXP |
diethyl maleate results in increased expression of CCNE2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccnk |
cyclin K |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CCNK mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 6:127,090,115...127,113,195
Ensembl chr 6:127,090,569...127,113,191
|
|
G |
Cd80 |
Cd80 molecule |
multiple interactions increases expression |
ISO |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein diethyl maleate results in increased expression of CD80 protein |
CTD |
PMID:31958493 |
|
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions increases expression |
ISO |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein; bisindolylmaleimide I inhibits the reaction [diethyl maleate results in increased expression of CD86 protein] |
CTD |
PMID:24136171 PMID:31958493 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdc25a |
cell division cycle 25A |
increases expression |
EXP |
diethyl maleate results in increased expression of CDC25A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdca2 |
cell division cycle associated 2 |
increases expression |
EXP |
diethyl maleate results in increased expression of CDCA2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdca3 |
cell division cycle associated 3 |
increases expression |
EXP |
diethyl maleate results in increased expression of CDCA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdca8 |
cell division cycle associated 8 |
increases expression |
EXP |
diethyl maleate results in increased expression of CDCA8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CDH11 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO |
diethyl maleate results in increased expression of CDKN1A mRNA; diethyl maleate results in increased expression of CDKN1A protein TP53 protein affects the reaction [diethyl maleate results in increased expression of CDKN1A protein] |
CTD |
PMID:11875189 PMID:27982581 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cds2 |
CDP-diacylglycerol synthase 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of CDS2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:119,514,963...119,553,555
Ensembl chr 3:119,515,000...119,553,541
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases expression increases reduction |
EXP ISO |
diethyl maleate results in decreased expression of CES1D protein diethyl maleate results in increased reduction of CES1D protein |
CTD |
PMID:19843705 PMID:21161181 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CFLAR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
increases expression |
ISO |
diethyl maleate results in increased expression of CHRNA4 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CIDEC mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CITED2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CITED4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:134,246,936...134,247,827
Ensembl chr 5:134,246,682...134,248,135
|
|
G |
Ckb |
creatine kinase B |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of CKB protein |
CTD |
PMID:19843705 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of CKS2 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clk1 |
CDC-like kinase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of CLK1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:59,947,764...59,957,000
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CMPK2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Cntn1 |
contactin 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of CNTN1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 7:123,263,146...123,560,896
Ensembl chr 7:123,372,792...123,558,541
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
EXP |
diethyl maleate results in decreased expression of COL1A1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
diethyl maleate results in decreased expression of COL3A1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Commd3 |
COMM domain containing 3 |
increases expression |
ISO |
diethyl maleate results in increased expression of COMMD3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177
|
|
G |
Comt |
catechol-O-methyltransferase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of COMT mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cp |
ceruloplasmin |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CP mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpsf4l |
cleavage and polyadenylation specific factor 4-like |
increases expression |
ISO |
diethyl maleate results in increased expression of CPSF4L mRNA |
CTD |
PMID:33545341 |
|
NCBI chr10:98,741,816...98,756,069
Ensembl chr10:98,743,649...98,751,590
|
|
G |
Crym |
crystallin, mu |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CRYM mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CSRP1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of CSRP3 protein |
CTD |
PMID:19843705 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CXCL10 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CXCL12 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CXCL9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cyb5a |
cytochrome b5 type A |
increases expression |
ISO |
diethyl maleate results in increased expression of CYB5A mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DBP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
diethyl maleate results in increased expression of DDIT3 mRNA; diethyl maleate results in increased expression of DDIT3 protein |
CTD |
PMID:33545341 PMID:35724838 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
diethyl maleate results in increased expression of DDIT4 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
increases expression |
ISO |
diethyl maleate results in increased expression of DDIT4L mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
|
|
G |
Ddx60 |
DEXD/H-box helicase 60 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DDX60 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DHX58 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
ISO |
diethyl maleate results in increased expression of DNAJB1 mRNA |
CTD |
PMID:33545341 PMID:34480604 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
diethyl maleate results in increased expression of DNAJB4 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnmbp |
dynamin binding protein |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DNMBP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:242,736,189...242,829,431
Ensembl chr 1:242,736,189...242,802,604
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of DPYSL2 protein |
CTD |
PMID:19843705 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Dtx3l |
deltex E3 ubiquitin ligase 3L |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DTX3L mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:64,814,926...64,824,539
Ensembl chr11:64,814,926...64,824,538
|
|
G |
Dus3l |
dihydrouridine synthase 3-like |
decreases expression |
ISO |
diethyl maleate results in decreased expression of DUS3L mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:1,593,491...1,598,663
Ensembl chr 9:1,594,123...1,598,655
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
diethyl maleate results in increased expression of DUSP6 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of EEF2K mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
ISO |
diethyl maleate results in increased expression of EGLN3 mRNA |
CTD |
PMID:34480604 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of EIF2AK2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
increases expression |
ISO |
diethyl maleate results in increased expression of ENTPD5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
|
|
G |
Eras |
ES cell expressed Ras |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ERAS mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:14,573,987...14,578,455
Ensembl chr X:14,573,987...14,578,374
|
|
G |
Ercc6l |
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
increases expression |
EXP |
diethyl maleate results in increased expression of ERCC6L mRNA |
CTD |
PMID:21161181 |
|
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
|
|
G |
Exo1 |
exonuclease 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of EXO1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of FABP1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FABP7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
affects expression |
ISO |
diethyl maleate affects the expression of FAH mRNA |
CTD |
PMID:34480604 |
|
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
increases expression |
ISO |
diethyl maleate results in increased expression of FAM83D mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FASN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FBN1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FBP1 protein |
CTD |
PMID:21161181 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fgf17 |
fibroblast growth factor 17 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FGF17 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:45,711,498...45,717,622
Ensembl chr15:45,711,998...45,717,063
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FGG mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FGR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FNDC3B mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
diethyl maleate results in increased expression of FOS mRNA |
CTD |
PMID:10915739 PMID:33545341 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [INS protein affects the localization of and results in increased phosphorylation of FOXO1 protein] |
CTD |
PMID:30261343 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Foxo3 |
forkhead box O3 |
increases expression |
ISO |
diethyl maleate results in increased expression of FOXO3 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Fstl3 |
follistatin like 3 |
increases expression |
ISO |
diethyl maleate results in increased expression of FSTL3 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 7:9,923,574...9,929,223
Ensembl chr 7:9,923,576...9,939,639
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of G6PC1 mRNA |
CTD |
PMID:25270620 PMID:30261343 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases activity increases expression |
EXP ISO |
diethyl maleate results in increased activity of G6PD protein diethyl maleate results in increased expression of G6PD mRNA |
CTD |
PMID:3099627 PMID:30261343 PMID:33545341 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gab1 |
GRB2-associated binding protein 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GAB1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr19:27,131,262...27,239,236
Ensembl chr19:27,131,262...27,239,236
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
diethyl maleate results in increased expression of GADD45A mRNA |
CTD |
PMID:33545341 PMID:34480604 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
diethyl maleate results in increased expression of GADD45G mRNA |
CTD |
PMID:33545341 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases reduction |
ISO |
diethyl maleate results in increased reduction of GAPDH protein |
CTD |
PMID:19843705 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gba2 |
glucosylceramidase beta 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GBA2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:57,822,389...57,834,522
Ensembl chr 5:57,822,389...57,834,072
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GBP2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases activity increases expression |
ISO EXP |
diethyl maleate results in increased activity of GCLC protein diethyl maleate results in increased expression of GCLC mRNA; diethyl maleate results in increased expression of GCLC protein |
CTD |
PMID:10915739 PMID:10978506 PMID:15115889 PMID:21465251 PMID:25270620 PMID:33545341 PMID:34021431 PMID:34480604 More...
|
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
EXP ISO |
diethyl maleate results in increased expression of GCLM mRNA; diethyl maleate results in increased expression of GCLM protein |
CTD |
PMID:10978506 PMID:15115889 PMID:21465251 PMID:25270620 PMID:33545341 PMID:34480604 More...
|
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
diethyl maleate results in increased expression of GCNT3 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
diethyl maleate results in increased expression of GDF15 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdf9 |
growth differentiation factor 9 |
increases expression |
ISO |
diethyl maleate results in increased expression of GDF9 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr10:37,589,200...37,599,970
Ensembl chr10:37,595,679...37,599,672
|
|
G |
Gfod1 |
Gfo/Idh/MocA-like oxidoreductase domain containing 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of GFOD1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GLUL mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GOT2 protein |
CTD |
PMID:21161181 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gpihbp1 |
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GPIHBP1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:107,285,584...107,288,702
Ensembl chr 7:107,285,654...107,288,702
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
affects expression |
ISO |
diethyl maleate affects the expression of GPX2 mRNA |
CTD |
PMID:34480604 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gria3 |
glutamate ionotropic receptor AMPA type subunit 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GRIA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
|
|
G |
Gsn |
gelsolin |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of GSN protein |
CTD |
PMID:19843705 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
diethyl maleate results in increased expression of GSR mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
increases expression |
EXP |
diethyl maleate results in increased expression of GSS mRNA |
CTD |
PMID:10978506 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
affects expression |
ISO |
diethyl maleate affects the expression of GSTA1 mRNA |
CTD |
PMID:34480604 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTA3 protein |
CTD |
PMID:9794803 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTA5 protein |
CTD |
PMID:9794803 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
multiple interactions |
ISO |
[diethyl maleate results in decreased abundance of Glutathione] which results in decreased expression of GSTK1 mRNA |
CTD |
PMID:22564015 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GSTM1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of GSTO1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTP1 protein |
CTD |
PMID:9794803 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTT1 protein |
CTD |
PMID:9794803 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of GTSE1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
|
|
G |
H2az2 |
H2A.Z variant histone 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of H2AZ2 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr14:81,293,304...81,312,209
Ensembl chr14:81,293,299...81,312,144 Ensembl chr 4:81,293,299...81,312,144 Ensembl chr16:81,293,299...81,312,144
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
increases expression |
ISO |
diethyl maleate results in increased expression of H6PD mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
increases expression |
ISO |
diethyl maleate results in increased expression of HAMP mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Helb |
DNA helicase B |
decreases expression |
ISO |
diethyl maleate results in decreased expression of HELB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:55,588,510...55,615,979
Ensembl chr 7:55,588,798...55,615,585
|
|
G |
Hes6 |
hes family bHLH transcription factor 6 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of HES6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
|
|
G |
Hjurp |
Holliday junction recognition protein |
increases expression |
EXP |
diethyl maleate results in increased expression of HJURP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:88,853,379...88,867,730
Ensembl chr 9:88,853,386...88,867,728
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of HMOX1 mRNA; diethyl maleate results in increased expression of HMOX1 protein |
CTD |
PMID:20491607 PMID:25270620 PMID:30261343 PMID:33545341 PMID:34480604 PMID:35724838 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of HNRNPH1 protein |
CTD |
PMID:19843705 |
|
NCBI chr10:34,692,868...34,702,849
Ensembl chr10:34,693,555...34,702,846
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
increases expression |
ISO |
diethyl maleate results in increased expression of HSD17B10 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of HSD17B2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
diethyl maleate results in increased expression of HSPA1B mRNA |
CTD |
PMID:33545341 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
increases expression |
ISO |
diethyl maleate results in increased expression of HSPA1L mRNA |
CTD |
PMID:33545341 |
|
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of HSPA5 protein |
CTD |
PMID:19843705 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of HSPA6 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases reduction |
ISO |
diethyl maleate results in increased reduction of HSPA8 protein |
CTD |
PMID:19843705 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of HTATIP2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Hycc2 |
hyccin PI4KA lipid kinase complex subunit 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of HYCC2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:60,056,883...60,129,176
Ensembl chr 9:60,056,890...60,093,007
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression multiple interactions |
ISO |
diethyl maleate results in decreased expression of ICAM1 mRNA diethyl maleate inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; NFE2L2 protein inhibits the reaction [diethyl maleate inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; RELA protein inhibits the reaction [diethyl maleate inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]] |
CTD |
PMID:25270620 PMID:35724838 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ID3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ID4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of IFIT3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of IFRD1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Ikbke |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
decreases expression |
ISO |
diethyl maleate results in decreased expression of IKBKE mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
increases expression |
ISO |
diethyl maleate results in increased expression of IKBKG mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
|
|
G |
Il10 |
interleukin 10 |
increases secretion |
ISO |
diethyl maleate results in increased secretion of IL10 protein |
CTD |
PMID:31958493 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
diethyl maleate results in increased expression of IL18 protein |
CTD |
PMID:23063874 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 mRNA]; diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 protein] |
CTD |
PMID:7476933 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; diethyl maleate inhibits the reaction [IL1B protein affects the localization of RELA protein]; diethyl maleate inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; diethyl maleate inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:35724838 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
affects expression |
ISO |
diethyl maleate affects the expression of IL1R1 mRNA |
CTD |
PMID:34480604 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein; [diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein |
CTD |
PMID:31958493 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Inhbb |
inhibin subunit beta B |
decreases expression |
ISO |
diethyl maleate results in decreased expression of INHBB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of INMT mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [INS protein affects the localization of and results in increased phosphorylation of FOXO1 protein] |
CTD |
PMID:30261343 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Ints7 |
integrator complex subunit 7 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of INTS7 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:103,155,123...103,207,953
Ensembl chr13:103,155,090...103,208,592
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of IRF7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irf9 |
interferon regulatory factor 9 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of IRF9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
|
|
G |
Irgm |
immunity-related GTPase M |
decreases expression |
EXP |
diethyl maleate results in decreased expression of IRGM mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Itgal |
integrin subunit alpha L |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ITGAL mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ITIH3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,101,930...6,116,924
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ITIH4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of JAM3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression increases phosphorylation |
ISO |
pyrazolanthrone inhibits the reaction [TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein]]; TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein] diethyl maleate results in increased expression of JUN protein modified form pyrazolanthrone inhibits the reaction [diethyl maleate results in increased expression of JUN protein modified form] diethyl maleate results in increased expression of JUN mRNA |
CTD |
PMID:10915739 PMID:12774022 PMID:30261343 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcne3 |
potassium voltage-gated channel subfamily E regulatory subunit 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of KCNE3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:154,523,903...154,530,865
Ensembl chr 1:154,523,830...154,532,020
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of KEAP1 mRNA; diethyl maleate results in increased expression of KEAP1 protein |
CTD |
PMID:27358234 PMID:33545341 PMID:34480604 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Khdrbs3 |
KH RNA binding domain containing, signal transduction associated 3 |
increases expression |
ISO |
diethyl maleate results in increased expression of KHDRBS3 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 7:100,837,707...100,995,644
Ensembl chr 7:100,837,934...100,988,460
|
|
G |
Kifc1 |
kinesin family member C1 |
increases expression |
EXP |
diethyl maleate results in increased expression of KIFC1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr20:4,998,832...5,017,107
Ensembl chr20:4,999,047...5,017,105
|
|
G |
Klf10 |
KLF transcription factor 10 |
decreases expression |
EXP ISO |
diethyl maleate results in decreased expression of KLF10 mRNA |
CTD |
PMID:21161181 PMID:25270620 |
|
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
|
|
G |
Krt75 |
keratin 75 |
increases reduction |
ISO |
diethyl maleate results in increased reduction of KRT75 protein |
CTD |
PMID:19843705 |
|
NCBI chr 7:132,687,101...132,697,360
Ensembl chr 7:132,688,237...132,697,345
|
|
G |
Lama1 |
laminin subunit alpha 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LAMA1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:107,692,770...107,816,847
Ensembl chr 9:107,692,770...107,817,478
|
|
G |
Lancl2 |
LanC like glutathione S-transferase 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LANCL2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:87,441,821...87,483,707
Ensembl chr 4:87,441,823...87,482,800
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LDLR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lepr |
leptin receptor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LEPR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lgals3bp |
galectin 3 binding protein |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LGALS3BP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
|
|
G |
Lmnb1 |
lamin B1 |
increases expression |
EXP |
diethyl maleate results in increased expression of LMNB1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lmo7 |
LIM domain 7 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LMO7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:78,566,999...78,769,833
Ensembl chr15:78,567,023...78,769,783
|
|
G |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LRIG3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:61,816,313...61,866,275
Ensembl chr 7:61,816,342...61,866,481
|
|
G |
Lrrn4 |
leucine rich repeat neuronal 4 |
increases expression |
EXP |
diethyl maleate results in increased expression of LRRN4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:120,138,093...120,150,877
Ensembl chr 3:120,139,410...120,150,831
|
|
G |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LRTM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:152,485,863...152,508,248
Ensembl chr 4:152,485,866...152,500,377
|
|
G |
Ltc4s |
leukotriene C4 synthase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LTC4S mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
|
|
G |
Lum |
lumican |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LUM mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
|
|
G |
Ly6c |
Ly6-C antigen |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LY6C mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:106,959,508...106,963,329
Ensembl chr 7:106,959,511...106,963,329
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
diethyl maleate results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 PMID:33545341 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
diethyl maleate results in increased expression of MAFG mRNA |
CTD |
PMID:33545341 PMID:34480604 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Maoa |
monoamine oxidase A |
increases expression |
ISO |
diethyl maleate results in increased expression of MAOA mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Mapk1ip1l |
mitogen-activated protein kinase 1 interacting protein 1-like |
increases expression |
ISO |
diethyl maleate results in increased expression of MAPK1IP1L mRNA |
CTD |
PMID:33545341 |
|
NCBI chr15:20,545,043...20,571,466
Ensembl chr15:20,545,059...20,569,674
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases expression multiple interactions |
ISO |
diethyl maleate results in increased expression of MAPK8 protein modified form pyrazolanthrone inhibits the reaction [diethyl maleate results in increased expression of MAPK8 protein modified form] |
CTD |
PMID:30261343 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions increases expression |
ISO |
pyrazolanthrone inhibits the reaction [diethyl maleate results in increased expression of MAPK9 protein modified form] |
CTD |
PMID:30261343 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Marveld1 |
MARVEL domain containing 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MARVELD1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:240,954,050...240,958,101
Ensembl chr 1:240,954,452...240,958,384
|
|
G |
Mboat7 |
membrane bound O-acyltransferase domain containing 7 |
increases expression |
ISO |
diethyl maleate results in increased expression of MBOAT7 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 1:65,525,206...65,539,538
Ensembl chr 1:65,525,213...65,539,538
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
increases expression |
EXP |
diethyl maleate results in increased expression of MCM10 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
increases expression |
EXP |
diethyl maleate results in increased expression of MCM4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of ME1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mfap4 |
microfibril associated protein 4 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MFAP4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases activity |
ISO |
diethyl maleate results in decreased activity of MGMT protein |
CTD |
PMID:16950796 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
EXP |
diethyl maleate results in increased expression of MKI67 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mknk2 |
MAPK interacting serine/threonine kinase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MKNK2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of MMP1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
increases expression |
ISO |
diethyl maleate results in increased expression of MMP12 mRNA |
CTD |
PMID:10216232 |
|
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MMP2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
diethyl maleate results in increased expression of MMP3 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mpzl1 |
myelin protein zero-like 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of MPZL1 mRNA |
CTD |
PMID:34480604 |
|
NCBI chr13:77,852,467...77,889,305
Ensembl chr13:77,852,467...77,896,616
|
|
G |
Msn |
moesin |
increases reduction |
ISO |
diethyl maleate results in increased reduction of MSN protein |
CTD |
PMID:19843705 |
|
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of MT1A mRNA |
CTD |
PMID:20491607 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
diethyl maleate results in increased expression of MT2A mRNA |
CTD |
PMID:20491607 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MX1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
|
|
G |
Mx2 |
MX dynamin like GTPase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MX2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:36,905,698...36,936,308
Ensembl chr11:36,906,111...36,930,342
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
increases expression |
EXP |
diethyl maleate results in increased expression of MYBL2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
diethyl maleate results in decreased expression of MYCN mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Nat8 |
N-acetyltransferase 8 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of NAT8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
|
|
G |
Ncaph |
non-SMC condensin I complex, subunit H |
increases expression |
EXP |
diethyl maleate results in increased expression of NCAPH mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of NDRG1 mRNA |
CTD |
PMID:33545341 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects localization increases activity increases expression multiple interactions decreases response to substance |
ISO EXP |
diethyl maleate affects the localization of NFE2L2 protein diethyl maleate results in increased activity of NFE2L2 protein diethyl maleate results in increased expression of NFE2L2 protein [diethyl maleate co-treated with TNF protein] results in decreased expression of NFE2L2 protein; diethyl maleate binds to and results in increased activity of NFE2L2 protein; diethyl maleate promotes the reaction [NFE2L2 protein binds to SMPD1 promoter]; diethyl maleate results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SMPD1 mRNA]; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein]; NFE2L2 protein inhibits the reaction [[diethyl maleate co-treated with TNF protein] results in decreased expression of SRXN1 protein]; NFE2L2 protein inhibits the reaction [diethyl maleate inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; NFE2L2 protein promotes the reaction [diethyl maleate results in increased expression of SRXN1 protein]; RELA protein inhibits the reaction [diethyl maleate results in increased expression of NFE2L2 protein]; RELA protein promotes the reaction [[diethyl maleate co-treated with TNF protein] results in decreased expression of NFE2L2 protein]; TNFAIP3 protein promotes the reaction [[diethyl maleate co-treated with TNF protein] results in decreased expression of NFE2L2 protein] NFE2L2 results in decreased susceptibility to diethyl maleate NFE2L2 gene mutant form inhibits the reaction [diethyl maleate results in increased expression of SLC7A11 mRNA]; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA]; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 mRNA] |
CTD |
PMID:12235164 PMID:20806931 PMID:21465251 PMID:22003191 PMID:25762726 | |